Fundraising FoxGilde Healthcare — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
Agendiaagendia.comin𝕏May 2012 · $65M
Agendia develops genomic technology and diagnostic tests for breast cancer patients.
AI & Machine LearningBiotechDigital HealthMedical DevicesIrvine, US
Laura van 't Veer(Co-founder)inRené Bernards(Co-founder)inProf. Laura van 't Veer, PhD(Chief Research Officer, Co-founder)Prof. Dr. René Bernards, PhD(Co-Founder and Scientific Advisor)Mark R. Straley(CEO)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.